Early Combination Therapy of Empagliflozin and Linagliptin Exerts Beneficial Effects on Pancreatic β Cells in Diabetic db/db Mice

Researchers elucidated the effects of dipeptidyl peptidase-4 inhibitor and/or sodium-glucose co-transporter 2 inhibitor on β-cell mass and function and compared their effects between in an early and advanced phase of diabetes.